Skip to main content
. 2024 Jun 5;29(9):786–793. doi: 10.1093/oncolo/oyae122

Table 1.

Enrolled patient characteristics.

All
N = 100
1*/1*
N = 47
*1/*28
N = 43
*28/*28
N = 10
Age median (range) 58 (19-79) 59 (38-79) 59 (19-72) 62 (52- 76)
Female n (%) 48 (48%) 22 (47%) 18 (42%) 8 (80%)
Race Black 12 (12%) 3 (6%) 7 (16%) 2 (20%)
White 83 (83%) 40 (85%) 35 (81%) 8 (80%)
Sites of metastatic disease 1 41 (41%) 20 (43%) 18 (42%) 3 (30%)
 ≥ 2 59 (59%) 27 (57%) 25 (58%) 7 (70%)
Somatic mutation
KRAS or NRAS Mutated 28 (28%) 9 (19%) 13 (30%) 5 (50%)
BRAF V600E 8 (8%) 6 (13%) 2 (5%) 0 (0%)